Wednesday, February 27, 2008

Regulatory Concerns in Named Patient Programs

Date: 2/19/2008
Length: 00:15:01
Size: 6.87MB


Thought Leader: Maria Kempshall, Head of Regulatory Affairs and Quality Assurance, IDIS

This is the second of three IDIS sponsored Podcasts covering named patient programs. In this episode, Ms. Kempshall gives a brief overview on the topic and then provides a detailed discussion on key regulatory issues, factors impacting pharmacovigilance, and finally, how to communicate the availability of a named patient program.


For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Wednesday, February 13, 2008

Navigating the Formulary Market

Date: 2/1/2008
Length: 00:14:26
Size: 6.60MB



Thought Leader: Jeff Thomas, President, inVentiv Strategy & Analytics

In this episode, Mr. Thomas discusses ways to develop effective formulary plans for new drugs and existing drugs with new indications, how to identify formulary opportunities, ways to use competitive intelligence in the plan development process, how brand managers can avoid common mistakes, and the best ways to communicate a plan to formulary decision makers.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

Tuesday, February 05, 2008

Named Patient Programs: An Overview

Date: 2/5/2008
Length: 00:18:17
Size: 8.37MB


Thought Leader: Natalie Douglas, CEO, IDIS

In this episode, Natalie Douglas provides an introduction to named patient programs, describes the factors that motivate pharmaceutical and biotech companies to implement these programs, and highlights the benefits to the patient as well as the sponsoring company.

Play Full Podcast

Download Related White Paper

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.

MSLs: An Evolving Specialty

Date: 1/24/2008
Length: 00:09:58
Size: 4.56MB

Thought Leader: Robin L. Winter-Sperry, M.D., President and CEO of Scientific Advantage LLC and MSL Advantage LLC

In this episode, Dr. Robin Winter-Sperry, President and CEO of Scientific Advantage LLC and MSL Advantage LLC, talks about the evolving role of the medical science liaison (MSL), return on education, how MSLs are improving patient outcomes, the growing trend of the inclusion of MSLs by emerging companies, and best practices for MSLs working in virtual teams.

Play Full Podcast

For more information on how you can be featured in a podcast, contact Dan Limbach at dlimbach@pharmavoice.com or call him at (847) 594-0157.